'Long-COVID': a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19
- PMID: 33172844
- PMCID: PMC7615158
- DOI: 10.1136/thoraxjnl-2020-215818
'Long-COVID': a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19
Abstract
Large numbers of people are being discharged from hospital following COVID-19 without assessment of recovery. In 384 patients (mean age 59.9 years; 62% male) followed a median 54 days post discharge, 53% reported persistent breathlessness, 34% cough and 69% fatigue. 14.6% had depression. In those discharged with elevated biomarkers, 30.1% and 9.5% had persistently elevated d-dimer and C reactive protein, respectively. 38% of chest radiographs remained abnormal with 9% deteriorating. Systematic follow-up after hospitalisation with COVID-19 identifies the trajectory of physical and psychological symptom burden, recovery of blood biomarkers and imaging which could be used to inform the need for rehabilitation and/or further investigation.
Keywords: respiratory infection; viral infection.
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures
Comment in
-
COVID-19 and what comes after?Thorax. 2021 Apr;76(4):324-325. doi: 10.1136/thoraxjnl-2020-216226. Epub 2021 Feb 15. Thorax. 2021. PMID: 33589513 No abstract available.
References
-
- British Society of Thoracic Imaging COVID-19 chest x-ray classification. [last accessed August 24th 2020]. Available at: https://www.bsti.org.uk/media/resources/files/BSTI_COVID_CXR_Proforma_v.... .
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials